Learn more about whether Glaukos Corporation or Inari Medical, Inc. is a better investment based on AAII's A+ Investor grades ...
An Abbott-funded report, written by leading vascular experts from the NHS, found that the health service could save more than ...
Finnish biopharmaceutical company Aplagon has secured a financing of €7m ($7.24m) to advance its heparin proteoglycan mimetic ...
Aplagon announces EUR 7 million financing to advance its APAC therapeutic for thrombo-inflammatory diseases into phase 2A trials: Helsinki Tuesday, February 4, 2025, 16:00 Hrs [IS ...
Cagent Vascular, Inc. announced the launch of its Serranator SL-Pro percutaneous transluminal angioplasty (PTA) serration ballo ...
Helsinki-based Aplagon has raised EUR 7 million to advance its APAC therapeutic for thrombo-inflammatory diseases into phase 2a clinical trials. Aki Prihti, CEO of Aplagon, said: “We’re delighted to ...
UK King’s Daughters became the first hospital in Kentucky — and the only hospital in the region — to offer a new minimally invasive procedure for ...
UroMems, a global medical technology company developing the first smart automated implant to treat stress urinary incontinence (SUI), announced today that Dan Rose has been appointed as the new ...
1 In its most severe form, critical limb ischemia patients are often treated with lower extremity amputation (LEA). 2 "We are dedicated to expanding innovative treatment options for peripheral artery ...